Recombinant Human Anti-CMV UL40 Soluble TCR (KK50.4) (C-Cys) (CAT#: VS-0622-YF3172)
Human TCR (KK50.4) recognizes CMV UL40 peptide (VMAPRTLIL) in the context of HLA-E*0103. Soluble TCR is expressed with C-terminal Cys strategy (TRAV-TRAC partial-Cys, TRBV-TRBC partial-Cys). Depending the C-terminal Cys, two chains form heterodimer. Please note that the activity is not guaranteed.
Specific Inquiry
Specifications
- Host Species
- Human
- Target
- CMV UL40
- Species Reactivity
- CMV
- Epitope
- VMAPRTLIL
- MHC
- HLA-E*0103
- Clone
- KK50.4
- Type
- Soluble TCR (C-Cys)
- Related Disease
- Cytomegalovirus infection
- TCR Expression Strategy
- C-Cys strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on C-terminal Cys. The soluble TCR contains variable regions and partial constant regions.
Target
- Alternative Names
- UL40; Protein UL40
- UniProt ID
- P16780
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone KK50.4"
See other products for "CMV UL40"
Select a product category from the dropdown menu below to view related products.
Please select product type
MHC Tetramer Products for Virology
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0622-YF3172. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: WB, IP, IF, FuncS, FC, Neut, ELISA
Application: Inhib, Cyt
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: ELISA, FC, WB, FuncS
Application: WB, ELISA, FuncS, Inhib, PK, IP, SPR
Application: ELISA, IHC, FC, IP, IF, Inhib
Application: ELISA, Inhib, FuncS
Application: FC, IA, IF, IP, IHC, FuncS
Application: ELISA, Cyt, PP, Inhib
Application: ELISA, FC, FuncS
Application: ELISA, Inhib, FuncS
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.